American Gene Technologies Competitors and Similar CompaniesClear all
American Gene Technologies's competitors and similar companies include Lupagen, 3D Medicines, HealthBanks Biotech and VLVbio.
 3D Medicines 3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs. |  VLVbio VLVbio is a company devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology. | ||||
Founding Date | Founding Date 2007 | Founding Date 2017 | Founding Date 2010 | Founding Date 2001 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Rockville, US HQ Rockville, US | Locations Dallas, US HQ | Locations Shanghai, CN HQ Singapore, SG Dubai, AE Fremont, US | Locations Irvine, US HQ | Locations HQ |
Employees | Employees 284% increase | Employees 3 | Employees 70030% decrease | Employees 14 | Employees 9 |
Funding | |||||
Latest funding round | Latest funding round $ 340k (over 11 years ago) | Latest funding round N/A | Latest funding round $ 140m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.6m | Total funding raised N/A | Total funding raised $ 281m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Lupagen
HQ
Dallas, US
Employees
3
Lupagen is a medical device company specializing in cell and gene therapies.
View company3D Medicines
HQ
Shanghai, CN
Employees
700↓ 30% decrease
3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs.
View company
HealthBanks Biotech
HQ
Irvine, US
Employees
14
HealthBanks Biotech is a company that provides cord blood banking solutions.
View companyVLVbio
HQ
Employees
9
VLVbio is a company devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology.
View company